• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of a new treatment for pseudomyxoma peritoneum using proteogenomic analysis and patient-derived models

Research Project

Project/Area Number 21K08743
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 55020:Digestive surgery-related
Research InstitutionNational Cancer Center Japan

Principal Investigator

Noguchi Rei  国立研究開発法人国立がん研究センター, 研究所, 研究員 (30779682)

Co-Investigator(Kenkyū-buntansha) 小迫 英尊  徳島大学, 先端酵素学研究所, 教授 (10291171)
近藤 格  国立研究開発法人国立がん研究センター, 研究所, 分野長 (30284061)
亀山 昭彦  国立研究開発法人産業技術総合研究所, 生命工学領域, 上級主任研究員 (80415661)
Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2023: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2022: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2021: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywordspseudomyxoma peritonei / patient-derived model / proteogenomics / 腹膜偽粘液腫 / 患者由来がんモデル / プロテオゲノミクス / 薬剤感受性試験 / 糖鎖
Outline of Research at the Start

本研究の目的は、希少で難治な腹膜偽粘液腫(Pseudomyxoma peritonei: PMP)の治療法の開発に向けて、病態の分子生物学的背景の理解に基づき、抗がん剤および治療標的を見つけることである。PMPの全ゲノムシークエンス解析・RNA-Seq解析を行い、患者由来PMP細胞株を樹立した。本研究では、PMPの腫瘍組織を用いてプロテオミゲノミクス解析を行い、治療標的を同定する。患者由来細胞株を用いて抗がん剤スクリーニングを行い、有効な抗がん剤を同定する。PMPが産生する粘液(ムチン)の特性を分子マトリックス電気泳動及び糖鎖修飾解析で明らかにし、粘液を減量・除去する方法に資する知見を得る。

Outline of Final Research Achievements

Pseudomyxoma peritoneum (PMP) is a rare cancer that manifests as symptoms caused by the dissemination of mucus-producing tumor cells into the peritoneal cavity. The mainstream treatment is a combination of excision of the primary tumor, removal of mucus, and intraperitoneal perfusion chemotherapy, which has improved the prognosis. However, postoperative recurrence and complications occur at a high rate, and the development of new treatment methods is required. The goal of the research is to find anticancer drugs and therapeutic targets for the development of treatments for PMP. In this study, we conducted drug screening using a PMP patient-derived cell line established by the applicant and identified effective anticancer drugs. We also established a protein extraction method from formalin-fixed specimens for proteogenomic analysis using large-scale specimens of PMP.

Academic Significance and Societal Importance of the Research Achievements

本研究成果により、腹膜偽粘液腫の患者由来細胞株を用いて、薬剤スクリーニングを行い、未だかつてない規模での薬剤の奏効性を調べることができた。また今までに取得した全ゲノムデータやRNA-Seqのデータから推測された治療標的から推測した薬剤と薬剤スクリーニングで実際奏効する薬剤の両方を検討することができた。これにより、患者由来モデルを用いての機能的アプローチと分子背景からの治療標的の同定の理論的アプローチの両方が重要であることがわかった。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (7 results)

All 2024 2023 2022 2021

All Journal Article (4 results) (of which Peer Reviewed: 4 results,  Open Access: 4 results) Presentation (3 results) (of which Invited: 2 results)

  • [Journal Article] Genome-Wide Analysis of DNA Methylation in Pseudomyxoma Peritonei Originated from Appendiceal Neoplasms2024

    • Author(s)
      Takane Kiyoko、Cai Tingwei、Noguchi Rei、Gohda Yoshimasa、Ikenoue Tsuneo、Yamaguchi Kiyoshi、Ota Yasunori、Kiyomatsu Tomomichi、Yano Hideaki、Fukuyo Masaki、Seki Motoaki、Bahityar Rahmutulla、Kaneda Atsushi、Furukawa Yoichi
    • Journal Title

      Oncology

      Volume: - Issue: 8 Pages: 1-12

    • DOI

      10.1159/000536219

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells2023

    • Author(s)
      Noguchi Rei、Yoshimatsu Yuki、Sin Yooksil、Ono Takuya、Tsuchiya Ryuto、Yoshida Hiroshi、Kiyono Tohru、Yonemura Yutaka、Kondo Tadashi
    • Journal Title

      Human Cell

      Volume: 37 Issue: 2 Pages: 511-522

    • DOI

      10.1007/s13577-023-01015-0

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. J. Pers. Med. 2022, 12, 2582023

    • Author(s)
      Noguchi Rei、Yoshimatsu Yuki、Sin Yooksil、Ono Takuya、Tsuchiya Ryuto、Yoshida Hiroshi、Kiyono Tohru、Yonemura Yutaka、Kondo Tadashi
    • Journal Title

      Journal of Personalized Medicine

      Volume: 13 Issue: 9 Pages: 1383-1383

    • DOI

      10.3390/jpm13091383

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei2022

    • Author(s)
      Noguchi Rei、Yoshimatsu Yuki、Sin Yooksil、Ono Takuya、Tsuchiya Ryuto、Yoshida Hiroshi、Kiyono Tohru、Yonemura Yutaka、Kondo Tadashi
    • Journal Title

      Journal of Personalized Medicine

      Volume: 12 Issue: 2 Pages: 258-258

    • DOI

      10.3390/jpm12020258

    • Related Report
      2023 Annual Research Report 2022 Research-status Report 2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] 超希少がん、腹膜偽粘液腫の治療開発:患者由来細胞株の樹立と抗がん剤の同定2022

    • Author(s)
      野口玲、吉松有紀、申育實、大﨑珠理亜、秋山太郎、安達雄輝、小野拓、 町田香織、栁原五吉、吉田裕、清野透、米村豊、近藤格
    • Organizer
      日本患者由来がんモデル学会
    • Related Report
      2022 Research-status Report
  • [Presentation] 腹膜偽粘液腫の基礎研究2021

    • Author(s)
      野口玲
    • Organizer
      第9階腹膜偽粘液腫患者の支援の会
    • Related Report
      2021 Research-status Report
    • Invited
  • [Presentation] 私と基礎研究 隣の芝生へ飛び込め!2021

    • Author(s)
      野口玲
    • Organizer
      武蔵野大学 薬学部
    • Related Report
      2021 Research-status Report
    • Invited

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi